Field & Main Bank’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.23M | Sell |
7,858
-578
| -7% | -$586K | 2.1% | 13 |
|
|
2025
Q4 | $9.07M | Buy |
8,436
+50
| +0.6% | +$47.8K | 2.61% | 10 |
|
|
2025
Q3 | $6.4M | Buy |
8,386
+19
| +0.2% | +$14.1K | 1.89% | 13 |
|
|
2025
Q2 | $6.52M | Sell |
8,367
-10
| -0.1% | -$7.77K | 2.12% | 8 |
|
|
2025
Q1 | $6.92M | Buy |
8,377
+70
| +0.8% | +$58.2K | 2.44% | 7 |
|
|
2024
Q4 | $6.41M | Buy |
8,307
+135
| +2% | +$112K | 2.26% | 9 |
|
|
2024
Q3 | $7.24M | Buy |
8,172
+27
| +0.3% | +$24.3K | 2.58% | 5 |
|
|
2024
Q2 | $7.37M | Buy |
8,145
+164
| +2% | +$131K | 2.76% | 5 |
|
|
2024
Q1 | $6.21M | Buy |
7,981
+259
| +3% | +$184K | 2.41% | 7 |
|
|
2023
Q4 | $4.5M | Buy |
7,722
+668
| +9% | +$390K | 1.9% | 11 |
|
|
2023
Q3 | $3.79M | Buy |
7,054
+4,905
| +228% | +$2.53M | 1.77% | 13 |
|
|
2023
Q2 | $1.01M | Buy |
2,149
+400
| +23% | +$168K | 0.56% | 55 |
|
|
2023
Q1 | $601K | Buy |
1,749
+770
| +79% | +$260K | 0.36% | 76 |
|
|
2022
Q4 | $358K | Buy |
979
+110
| +13% | +$39K | 0.23% | 97 |
|
|
2022
Q3 | $281K | Sell |
869
-7
| -0.8% | -$2.22K | 0.19% | 106 |
|
|
2022
Q2 | $284K | Buy |
876
+7
| +0.8% | +$2.1K | 0.18% | 107 |
|
|
2022
Q1 | $249K | Hold |
869
| – | – | 0.15% | 107 |
|
|
2021
Q4 | $240K | Hold |
869
| – | – | 0.14% | 113 |
|
|
2021
Q3 | $201K | Sell |
869
-10
| -1% | -$2.47K | 0.13% | 112 |
|
|
2021
Q2 | $202K | Hold |
879
| – | – | 0.13% | 113 |
|
|
2021
Q1 | $164K | Hold |
879
| – | – | 0.12% | 114 |
|
|
2020
Q4 | $148K | Sell |
879
-9
| -1% | -$1.34K | 0.11% | 107 |
|
|
2020
Q3 | $131K | Hold |
888
| – | – | 0.1% | 108 |
|
|
2020
Q2 | $146K | Buy |
+888
| New | +$136K | 0.12% | 104 |
|
|
2019
Q4 | $117K | Hold |
888
| – | – | 0.1% | 110 |
|
|
2019
Q3 | $99K | Hold |
888
| – | – | 0.09% | 116 |
|
|
2019
Q2 | $98K | Hold |
888
| – | – | 0.09% | 120 |
|
|
2019
Q1 | $115K | Buy |
+888
| New | +$108K | 0.11% | 116 |
|
|
2018
Q3 | $95K | Sell |
888
-39
| -4% | -$3.9K | 0.08% | 129 |
|
|
2018
Q2 | $92K | Buy |
927
+78
| +9% | +$6.41K | 0.08% | 131 |
|
|
2018
Q1 | $66K | Hold |
849
| – | – | 0.06% | 146 |
|
|
2017
Q4 | $72K | Buy |
+849
| New | +$72.2K | 0.07% | 137 |
|
|
2015
Q2 | $71K | Hold |
849
| – | – | 0.07% | 117 |
|
|
2015
Q1 | $62K | Sell |
849
-100
| -11% | -$7.12K | 0.06% | 114 |
|
|
2014
Q4 | $65K | Buy |
949
+100
| +12% | +$6.75K | 0.06% | 116 |
|
|
2014
Q3 | $55K | Hold |
849
| – | – | 0.05% | 116 |
|
|
2014
Q2 | $53K | Hold |
849
| – | – | 0.05% | 116 |
|
|
2014
Q1 | $50K | Hold |
849
| – | – | 0.05% | 116 |
|
|
2013
Q4 | $43K | Buy |
+849
| New | +$42.5K | 0.04% | 122 |
|
Other funds holding LLY
VCM
VPM
Field & Main Bank's LLY Position: Q1 2026 in Review
Field & Main Bank reduced its Eli Lilly (LLY) stake by 6.9% in Q1 2026, selling an estimated $586K and leaving 7,858 shares worth $7.23M. The position accounts for 2.1% of the portfolio, ranked #13.
Field & Main Bank first reported a position in LLY in Q4 2013 and has held it in 39 quarters since. The position peaked at $9.07M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Field & Main Bank held 7,858 shares of Eli Lilly worth $7.23M as of Q1 2026.
- Field & Main Bank sold 578 Eli Lilly shares in Q1 2026, an estimated $586K.
- Eli Lilly made up 2.1% of Field & Main Bank's portfolio in Q1 2026, its #13 holding.
- Field & Main Bank first reported a position in Eli Lilly in Q4 2013 and has held it in 39 quarters since.
- Field & Main Bank's Eli Lilly position peaked at $9.07M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Field & Main Bank's 13F filing for Q1 2026, filed 10 Apr 2026.